Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1991 2
1994 2
1996 2
1998 2
2003 1
2004 2
2005 4
2006 1
2007 4
2009 2
2010 1
2011 2
2012 3
2013 7
2014 3
2015 3
2016 2
2017 6
2018 13
2019 8
2020 8
2021 9
2022 9
2023 9
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban: searching the integral vascular protection.
Barrios V, Almendro-Delia M, Facila L, Garcia-Moll X, Mazón P, Camafort M, Cepeda JM, Mediavilla Garcia JD, Pose Reino A, Suarez Fernandez C. Barrios V, et al. Among authors: suarez fernandez c. Expert Rev Clin Pharmacol. 2018 Jul;11(7):719-728. doi: 10.1080/17512433.2018.1495559. Epub 2018 Jul 18. Expert Rev Clin Pharmacol. 2018. PMID: 29965791 Review.
Role of rivaroxaban in the prevention of atherosclerotic events.
Sanmartín M, Bellmunt S, Cosín-Sales J, García-Moll X, Riera-Mestre A, Almendro-Delia M, Hernández JL, Lozano F, Mazón P, Suarez Fernández C. Sanmartín M, et al. Among authors: suarez fernandez c. Expert Rev Clin Pharmacol. 2019 Aug;12(8):771-780. doi: 10.1080/17512433.2019.1637732. Epub 2019 Jul 9. Expert Rev Clin Pharmacol. 2019. PMID: 31269825 Review.
[Association of antiagregants: when and how].
López Menchaca R, Herrero Martínez JM, Suárez Fernández C. López Menchaca R, et al. Among authors: suarez fernandez c. Med Clin (Barc). 2007 Mar 17;128(10):383-9. doi: 10.1157/13099977. Med Clin (Barc). 2007. PMID: 17386246 Review. Spanish.
Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
Gullón A, Sánchez Fuentes D, López-de-Sá E, Martí-Almor J, Barón-Esquivias G, Jiménez López J, Del Mar Contreras Muruaga M, Suárez Fernández C. Gullón A, et al. Among authors: suarez fernandez c. Med Clin (Barc). 2018 Jun;150 Suppl 1:8-24. doi: 10.1016/S0025-7753(18)30666-3. Med Clin (Barc). 2018. PMID: 30502871 Review. English, Spanish.
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition.
González-Juanatey JR, Almendro-Delia M, Cosín-Sales J, Bellmunt-Montoya S, Gómez-Doblas JJ, Riambau V, García-Moll X, García-Alegría J, Hernández JL, Lozano FS, Suarez Fernández C. González-Juanatey JR, et al. Among authors: suarez fernandez c. Expert Rev Clin Pharmacol. 2020 Jul;13(7):695-706. doi: 10.1080/17512433.2020.1772056. Expert Rev Clin Pharmacol. 2020. PMID: 32434452 Review.
Temporomandibular Disorders Management-What's New? A Scoping Review.
Mauro G, Verdecchia A, Suárez-Fernández C, Nocini R, Mauro E, Zerman N. Mauro G, et al. Among authors: suarez fernandez c. Dent J (Basel). 2024 May 23;12(6):157. doi: 10.3390/dj12060157. Dent J (Basel). 2024. PMID: 38920858 Free PMC article. Review.
Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial.
Hernández JL, Lozano FS, Riambau V, Almendro-Delia M, Cosín-Sales J, Bellmunt-Montoya S, Garcia-Alegria J, Garcia-Moll X, Gomez-Doblas JJ, Gonzalez-Juanatey JR, Suarez Fernández C. Hernández JL, et al. Among authors: suarez fernandez c. Drugs Context. 2020 Jul 6;9:2020-5-5. doi: 10.7573/dic.2020-5-5. eCollection 2020. Drugs Context. 2020. PMID: 32699549 Free PMC article. Review.
103 results